2022
DOI: 10.3390/cancers14174289
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Potential for Targeting Autophagy in ER+ Breast Cancer

Abstract: While endocrine therapy remains the mainstay of treatment for ER-positive, HER2-negative breast cancer, tumor progression and disease recurrence limit the utility of current standards of care. While existing therapies may allow for a prolonged progression-free survival, however, the growth-arrested (essentially dormant) state of residual tumor cells is not permanent and is frequently a precursor to disease relapse. Tumor cells that escape dormancy and regain proliferative capacity also tend to acquire resistan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
35
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(35 citation statements)
references
References 78 publications
0
35
0
Order By: Relevance
“…Since the death was not from apoptosis in PAK4-knockdown hepatocarcinoma cells in our previous study (33), and p53 (25,26,34) and PAKs (16,19,21) were relevant with autophagy in cancer cells, the present study focused on autophagy. To date, main functional forms in autophagy are proposed to be cytotoxic, cytostatic, and cytoprotective in the context of antitumor therapy: cytotoxic autophagy leads to cancer cell death, cytostatic autophagy inhibits cancer cell propagation, and cytoprotective autophagy enhances cancer cells' drug sensitivity (35). Our findings showed an increased autophagosome by MDC staining and expression of autophagic biomarker LC3-II/LC3-I, suggesting an increased autophagy inhibiting propagation in PAK4knockdown HepG2 cells.…”
Section: Discussionmentioning
confidence: 53%
“…Since the death was not from apoptosis in PAK4-knockdown hepatocarcinoma cells in our previous study (33), and p53 (25,26,34) and PAKs (16,19,21) were relevant with autophagy in cancer cells, the present study focused on autophagy. To date, main functional forms in autophagy are proposed to be cytotoxic, cytostatic, and cytoprotective in the context of antitumor therapy: cytotoxic autophagy leads to cancer cell death, cytostatic autophagy inhibits cancer cell propagation, and cytoprotective autophagy enhances cancer cells' drug sensitivity (35). Our findings showed an increased autophagosome by MDC staining and expression of autophagic biomarker LC3-II/LC3-I, suggesting an increased autophagy inhibiting propagation in PAK4knockdown HepG2 cells.…”
Section: Discussionmentioning
confidence: 53%
“…Thus, it would appear that sex, specifically sex hormones, may be the determining factor for the regulation of autophagy. Moreover, it is important to note that the upregulation of autophagy genes is beneficial to a certain degree, as it has been found to lead to cell death and cancer if overexpressed (Finnegan et al 2022).…”
Section: Discussionmentioning
confidence: 99%
“…Autophagy is an adaptive response that tumor cells depend on for survival, particularly during periods of chemotherapeutic or targeted drug therapy. Protective autophagy, activated by numerous signaling pathways, supplies nutrition to cancer cells to maintain their growth and migration while also making them resistant to therapy [ 51 , 52 ]. As a result, autophagy suppression is often exploited as a target to increase cancer cell susceptibility to medicines.…”
Section: Natural Products Overcome Autophagy-mediated Tumor Drug Resi...mentioning
confidence: 99%